Loading BRNS…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("BRNS","financials")Full statements spill as a table. For one cell: =jivedata("BRNS","Revenue") or =jivedata("BRNS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
BRNS • CIK 0001828185
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $802 | $14,969 | $0 | $0 |
| Other Operating Income | — | $1,176 | $506 | $215 |
| Operating Income (Loss) | $-83,914 | $-67,970 | $-70,555 | $-43,725 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $-76,522 | $-61,227 | $-66,633 | $-41,974 |
| Income Tax Expense (Benefit) | $-3,075 | $-44 | $-175 | $-167 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-73,447 | $-61,183 | $-66,458 | $-41,807 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $-100 | $-109 | $-30 | $-40 |
| Net Income (Loss) Attributable to Parent | $-73,347 | $-61,074 | $-66,428 | $-41,767 |
| Weighted Average Number of Shares Outstanding, Basic | 38,386,491 | 39,348,240 | 40,527,218 | 41,071,527 |
| Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | $10,151 | $-2,549 | $10,145 | $-4,810 |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | $-63,296 | $-63,732 | $-56,313 | $-46,617 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | $-94 | $-105 | $-22 | $-43 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $-63,202 | $-63,627 | $-56,291 | $-46,574 |
| Research and Development Expense | $44,874 | $42,236 | $25,564 | $16,837 |
| General and Administrative Expense | $39,842 | $29,670 | $40,830 | $22,436 |
| Impairment of Intangible Assets, Finite-lived | — | $0 | $4,667 | $4,667 |
| Goodwill, Impairment Loss | $0 | $12,209 | $0 | $0 |
| Operating Expenses | $84,716 | $84,115 | $71,061 | $43,940 |
| Investment Income, Interest | $2,877 | $2,678 | $1,957 | $1,571 |
| InterestExpenseNonoperating | — | $53 | $51 | $53 |
| Other Nonoperating Income (Expense) | $1,082 | $135 | $16 | $-314 |
| Nonoperating Income (Expense) | $7,392 | $6,743 | $3,922 | $1,751 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $142,090 | $110,662 | $70,456 | $59,295 |
| Restricted Cash, Current | — | $1,738 | $1,396 | $335 |
| Property, Plant and Equipment, Net | $11,821 | $7,373 | $3,523 | $3,038 |
| Intangible Assets, Net (Excluding Goodwill) | $25,108 | $21,947 | $14,288 | $13,045 |
| Prepaid Expense and Other Assets, Current | $9,907 | $6,203 | $4,830 | $2,362 |
| Operating Lease, Right-of-Use Asset | $7,581 | $4,384 | $1,638 | $1,618 |
| Assets, Current | $156,905 | $125,742 | $77,790 | $63,273 |
| Other Assets | $882 | $881 | $930 | $919 |
| Assets | $214,506 | $160,327 | $98,169 | $81,893 |
| Accounts Payable, Current | $1,601 | $2,474 | $350 | $535 |
| Operating Lease, Liability, Current | $1,785 | $1,920 | $2,023 | $1,724 |
| Liabilities, Current | $12,598 | $15,657 | $10,018 | $11,423 |
| Operating Lease, Liability, Noncurrent | $11,191 | $10,087 | $9,258 | $8,571 |
| Business Combination, Contingent Consideration, Liability, Noncurrent | $1,823 | $2,650 | $2,871 | $3,063 |
| Other Liabilities, Noncurrent | $1,325 | $1,360 | $1,476 | $1,487 |
| Deferred Income Tax Liabilities, Net | $11,750 | $438 | $254 | $215 |
| Liabilities | $27,511 | $30,192 | $23,877 | $24,759 |
| Common Stock, Value, Issued | $1 | $1 | $1 | $1 |
| Additional Paid in Capital | $386,602 | $393,474 | $393,944 | $394,932 |
| Retained Earnings (Accumulated Deficit) | $-176,590 | $-237,664 | $-304,092 | $-320,208 |
| Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax | $-23,315 | $-25,868 | $-15,731 | $-17,738 |
| Stockholders' Equity Attributable to Parent | $186,784 | $130,029 | $74,208 | $57,073 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $211 | $106 | $84 | $61 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $186,995 | $130,135 | $74,292 | $57,134 |
| Common Stock, Shares Authorized | 38,643,540 | 40,234,663 | 40,848,893 | 40,848,893 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-73,447 | $-61,183 | $-66,458 | $-41,807 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | $2,171 | $-2,021 | $7,013 | $-2,298 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-52,295 | $-29,690 | $-40,548 | $-28,154 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $142,090 | $112,400 | $71,852 | $38,462 |
| Share-based Payment Arrangement, Noncash Expense | $5,055 | $4,709 | $468 | $1,270 |
| Proceeds from Sale of Property, Plant, and Equipment | $0 | — | $453 | $569 |
| Payments to Acquire Property, Plant, and Equipment | $5,413 | $892 | $37 | $0 |
| Goodwill, Impairment Loss | $0 | $12,209 | $0 | $0 |
| Net Cash Provided by (Used in) Investing Activities | $-5,413 | $-892 | $416 | $569 |
| Depreciation, Depletion and Amortization | $5,429 | $5,800 | $5,845 | $3,486 |
| Foreign Currency Transaction Gain (Loss), Unrealized | $-7,531 | $649 | $-3,742 | $2,400 |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $55 | $866 | $26 | $538 |
| Deferred Income Tax Expense (Benefit) | $-3,075 | $-44 | $-175 | $-167 |
| Gain (Loss) on Disposition of Property Plant Equipment | $0 | — | $245 | $34 |
| Net Cash Provided by (Used in) Operating Activities | $-50,925 | $-28,940 | $-47,979 | $-26,425 |
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | $0 | $0 | $2 | $0 |
| Proceeds from Issuance of Common Stock | $2,035 | $2,163 | $0 | $0 |
| Net Cash Provided by (Used in) Financing Activities | $1,872 | $2,163 | $2 | $0 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $-2,200 | $-3,643 | $-1,704 | $-4,679 |
| Increase (Decrease) in Accounts Payable | $-3,378 | $898 | $-2,202 | $-1,196 |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | $1,993 | $456 | $-3,793 | $1,664 |
| Increase (Decrease) in Deferred Revenue | — | $1,738 | $-506 | $-1,215 |
| IncreaseDecreaseInOperatingLeaseLiability | $-445 | $-1,789 | $-1,979 | $-2,311 |